P
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A122.7 KBPrincipia Biopharma Inc.Feb 16, 3:13 PM ET·0000929638-21-000373
- SC 13D/A48.6 KBPrincipia Biopharma Inc.Sep 30, 9:00 PM ET·0001387131-20-008670
- 8-K285.5 KBPrincipia Biopharma Inc.Sep 28, 8:42 AM ET·0001193125-20-255598
- SC 13G/A8.4 KBPrincipia Biopharma Inc.Sep 10, 10:03 AM ET·0000315066-20-001730
- SC 13D375.0 KBPrincipia Biopharma Inc.Aug 25, 12:32 PM ET·0000921895-20-002317
- SC 13G291.2 KBPrincipia Biopharma Inc.Aug 19, 1:49 PM ET·0000921895-20-002285
- 8-K802.8 KBPrincipia Biopharma Inc.Aug 17, 6:31 AM ET·0001193125-20-221651
- 10-Q8.7 MBPrincipia Biopharma Inc.Aug 6, 4:31 PM ET·0001564590-20-037804
- 8-K390.9 KBPrincipia Biopharma Inc.Aug 6, 4:17 PM ET·0001564590-20-037763
- 8-K203.6 KBPrincipia Biopharma Inc.Jun 26, 4:05 PM ET·0001564590-20-030809
Insiders
10- AKKARAJU SRINIVASDirector
- Babler MartinDirector, Chief Executive Officer
- Baker Bros. Advisors (GP) LLC10% Owner
- BAKER BROS. ADVISORS LP10% Owner
- BAKER FELIX10% Owner
- BAKER JULIAN10% Owner
- Becker Daniel J.Director, 10% Owner
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- Biotechnology Value Trading Fund OS LPSee Explanation of Responses
- BVF GP HOLDINGS LLC10% Owner
Tickers
No tickers on record
Addresses
business
220 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA, 94080
mailing
220 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA, 94080